Clinical Trial Update: Monoclonal Antibody for Treatment of Inhalation Anthrax [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of a monoclonal antibody for inhalation anthrax has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inhalation Anthrax

Drugs mentioned

• Monoclonal antibody for inhalation anthrax (unspecified)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Bacillus Anthracis (Anthrax) | Phase 1 | Status: COMPLETED